Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in South India

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 98, Issue 3, 2004, Pages 174-181

  Rajendran, R ^a   Sunish, I P ^a   Mani, T R ^a   Munirathinam, A ^a   Abdullah, S Md ^b   Arunachalam, N ^a   Satyanarayana, K ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b Government of Tamil Nadu   (India)

Author keywords

Albendazole; Antigenaemia; Bancroftian filariasis elimination; Diethylcarbamazine; India; Microfilaraemia

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; PARASITE ANTIGEN; ANTHELMINTIC AGENT;

ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; CHILD; CHILDHOOD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG POTENTIATION; ERADICATION THERAPY; GEOMETRY; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INDIA; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; MASS SCREENING; MICROFILARIASIS; MONOTHERAPY; NONHUMAN; PREVALENCE; SERODIAGNOSIS; SEROPREVALENCE; SINGLE DRUG DOSE; TREATMENT OUTCOME; WUCHERERIA BANCROFTI; ANIMAL; BLOOD; CROSS-SECTIONAL STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; ELEPHANTIASIS; PATIENT COMPLIANCE; PRESCHOOL CHILD;

WUCHERERIA; WUCHERERIA BANCROFTI;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIETHYLCARBAMAZINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELEPHANTIASIS, FILARIAL; HUMANS; PATIENT COMPLIANCE; TREATMENT OUTCOME; WUCHERERIA BANCROFTI;

EID: 1842557323     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)00042-7     Document Type: Article

References (27)

1. Addiss, D.G., Dreyer, G., 2000. Treatment of lymphatic filariasis, in Nutman, T.B. (Ed.), Lymphatic Filariasis. Imperial College Press, London. 151-199.
2. Bockarie M.J. Alexander N.D. Hyun P. Dimber Z. Bockarie F. Ibam E. Alpers M.P. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes Lancet 351 1998 162-168
3. Bockarie M.J. Tisch D.J. Kastens W. Alexander N.D.E. Dimber Z. Bockarie F. Ibam E. Alpers M.P. Kazura J.W. Mass treatment to eliminate filariasis in Papua New Guinea N. Eng. J. Med. 347 2002 1841-1848
4. Das P.K. Ramaiah K.D. Augustin D.J. Kumar A. Towards elimination of lymphatic filariasis in India Trends Parasitol. 17 2001 457-460
5. Day K.P. Spark R. Garner P. Raiko A. Wenger J.D. Weiss N. Mitchell G.F. Alpers M.P. Kazura J.W. Serological evaluation of the macrofilaricidal effects of diethylcarbamazine treatment in bancroftian filariasis. Am. J. Trop. Med. Hyg. 44 1991 528-535
6. Dreyer G. Noroes J. Addiss D. Santos A. Medeiros Z. Figueredo-Silva J. Bancroftian filariasis in a paediatric population: an ultrasonographic study Trans. R. Soc. Trop. Med. Hyg. 93 1999 633-636
7. Eberhard M.L. Hightower A.W. Addiss D.G. Lammie P.J. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin Am. J. Trop. Med. Hyg. 57 1997 483-486
8. Freedman D.O. Plier D.A. De Almeida A.B. De Oliveira A.L. Miranda J. Braga C. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis Trop. Med. Int. Health 6 2001 37-41
9. Freeman A.R. Lammie P.J. Houston R. Lapointe M.D. Streit G.T. Jooste P.L. Brissau J.M. Lafontant J.G. Addiss D.G. A community-based trial for the control of lymphatic filariasis and iodine deficiency using salt fortified with diethylcarbamazine and iodine Am. J. Trop. Med. Hyg. 65 2001 865-871
10. Ismail M.M. Jayakody R.L. Weil G.J. Fernando D. De Silva M.S.G. De Silva G. Balasooriya W.K. Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis Trans. R. Soc. Trop. Med. Hyg. 95 2001 332-335
11. Lammie P.J. Hightower A.W. Eberhard M.L. Age specific prevalence of antigenaemia in a Wuchereria bancrofti-exposed population Am. J. Trop. Med. Hyg. 51 1994 348-355
12. Mani T.R. Rajendran R. Munirathinam A. Sunish I.P. Abdullah S.M. Augustin D.J. Satyanarayana K. Efficacy of co-administration of albendazole and diethylcarbamazine on geohelminthiases: a study from South India Trop. Med. Int. Health 7 2002 541-548
13. Noroes J. Dreyer G. Santos A. Mendes V.G. Mendeiros Z. Addiss D. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo Trans. R. Soc. Trop. Med. Hyg. 91 1997 78-81
14. Ottesen E.A. Major progress toward eliminating lymphatic filariasis N. Engl. J. Med. 347 2002 1885-1886
15. Ottesen E.A. Ismail M.M. Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis Parasitol. Today 15 1999 382-386
16. Rajendran R. Sunish I.P. Mani T.R. Munirathinam A. Abdullah S.M. Augustin D.J. Satyanarayana K. The influence of mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia Ann. Trop. Med. Parasitol. 96 2002a 595-602
17. Rajendran R. Sunish I.P. Mani T.R. Munirathinam A. Satyanarayana K. Targeting of children in filariasis mass drug administration Lancet 360 2002 1430
18. Rajendran, R., Mani, T.R., Munirathinam, A., Sunish, I.P., Abdullah, S.M., Augustin, D.J., Satyanarayana, K., 2003. Sustainability of soil-transmitted helminths control following a single-dose co-administration of albendazole and diethylcarbamazine, Trans. R. Soc. Trop. Med. Hyg. (in press).
19. Ramaiah K.D. Vanamail P. Pani S.P. Yuvaraj J. Das P.K. The effects of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination Trop. Med. Int. Health 7 2002 767-774
20. Reuben R. Rajendran R. Sunish I.P. Mani T.R. Tewari S.C. Hiriyan J. Gajanana A. Annual single dose diethylcarbamazine plus ivermectin for control of bancroftian filariasis: comparative efficacy with and without vector control Ann. Trop. Med. Parasitol. 95 2001 361-378
21. Steel C. Ottesen E.A. Weller P.F. Nutman T.B. Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific Am. J. Trop. Med. Hyg. 65 2001 498-503
22. Sunish I.P. Rajendran R. Mani T.R. Munirathinam A. Tewari S.C. Hiriyan J. Gajanana A. Satyanarayana K. Resurgence in filarial transmission after withdrawal of mass drug administration and the inter-relationship between antigenaemia and microfilaraemia - a longitudinal study Trop. Med. Int. Health 7 2002 59-69
23. Sunish I.P. Rajendran R. Satyanarayana K. Munirathinam A. Gajanana A. Immunochromatographic test (ICT) for estimation of true prevalence of bancroftian filariasis in an endemic area in southern India Trans. R. Soc. Trop. Med. Hyg. 95 2001 605-607
24. Tisch D.J. Hazlett F.E. Kastens W. Alpers M.P. Bockarie M.J. Kazura J.W. Ecologic and biologic determinants of filarial antigenaemia in bancroftian filariasis in Papua New Guinea J. Infect. Dis. 184 2001 898-904
25. Weil G.J. Sethumadhavan K.V. Santhanam S. Jain D.C. Ghosh T.K. Persistence of parasite antigenaemia following diethylcarbamazine therapy of bancroftian filariasis Am. J. Trop. Med. Hyg. 38 1988 589-595
26. WHO, 1999. Collaborative global programme to eliminate lymphatic filariasis: Programmes background and overview towards initiating a National programme to eliminate lymphatic filariasis. WHO/CEE/FIL World Health Organization, Geneva, 1-25.
27. Witt C. Ottesen E.A. Lymphatic filariasis: an infection of childhood Trop. Med. Int. Health 8 2001 582-606